Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Assets (2021 - 2025)

Zymeworks' Assets history spans 5 years, with the latest figure at $346.5 million for Q4 2025.

  • On a quarterly basis, Assets fell 25.17% to $346.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $346.5 million, a 25.17% decrease, with the full-year FY2025 number at $346.5 million, down 25.17% from a year prior.
  • Assets hit $346.5 million in Q4 2025 for Zymeworks, down from $397.3 million in the prior quarter.
  • Over the last five years, Assets for ZYME hit a ceiling of $648.7 million in Q4 2022 and a floor of $300.3 million in Q3 2022.
  • Historically, Assets has averaged $485.0 million across 5 years, with a median of $487.2 million in 2024.
  • Biggest five-year swings in Assets: surged 85.29% in 2023 and later dropped 25.17% in 2025.
  • Tracing ZYME's Assets over 5 years: stood at $389.1 million in 2021, then surged by 66.71% to $648.7 million in 2022, then fell by 10.46% to $580.9 million in 2023, then fell by 20.28% to $463.1 million in 2024, then dropped by 25.17% to $346.5 million in 2025.
  • Business Quant data shows Assets for ZYME at $346.5 million in Q4 2025, $397.3 million in Q3 2025, and $408.4 million in Q2 2025.